This information was published on 2026-02-23T15:05 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2574727 (IR 1869197) |
| (220) |
01 Apr 2025
|
| (300) |
CH, 26 Feb 2025, 828765
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
The applicant has advised that the words in the Mark have no meaning in English |
| (511) (510) |
Class 38
Provision of access to online forums for healthcare professionals and scientists to enhance collaboration and information exchange in the field of radioligand imaging and therapy research. Class 41 Organization and hosting of conferences, congresses and symposia for healthcare professionals and scientists in the field of radioligand imaging and therapy; Educational services, namely the provision of seminars and non-downloadable webinars for healthcare professionals and scientists in the field of radioligand imaging and therapy. Class 42 Hosting of non-downloadable online computer software platforms for healthcare professionals and scientists to enhance collaboration and information sharing in the field of radioligand imaging and therapy research. |
| (540) | BRIGHTER |
| (550) | Word |
| (730) |
Novartis AG
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.